Raleigh Capital Management Inc. Merck & Co., Inc. Transaction History

Raleigh Capital Management Inc.

$229 Million
Q1 2024

A detailed history of Raleigh Capital Management Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 12,729 shares of MRK stock, worth $1.6 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares

12,729

Previous 12,238 4.01%

Holding current value

$1.6 Million

Previous $1.33 Million 25.86%

% of portfolio

0.73%

Previous 0.63%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$113.24 - $131.95 $55,600 - $64,787	491 Added 4.01%	12,729 $1.68 Million
Q4 2023 Feb 21, 2024	SELL	$100.18 - $109.02 $601 - $654	-6 Reduced 0.05%	12,238 $1.33 Million
Q3 2023 Dec 07, 2023	BUY	$102.95 - $114.33 $23,163 - $25,724	225 Added 1.87%	12,244 $1.26 Million
Q3 2023 Dec 06, 2023	SELL	$102.95 - $114.33 $240,491 - $267,074	-2,336 Reduced 16.27%	12,019 $1.24 Million
Q2 2023 Jul 25, 2023	SELL	$108.61 - $118.38 $31,605 - $34,448	-291 Reduced 1.99%	14,355 $1.66 Million

Q1 2023 May 22, 2023	SELL	$102.94 - $114.86 $738,594 - $824,120	-7,175 Reduced 32.88%	14,646 $1.56 Million
Q4 2022 Feb 07, 2023	SELL	$87.44 - $112.11 $585,673 - $750,912	-6,698 Reduced 23.49%	21,821 $2.42 Million
Q3 2022 Nov 09, 2022	SELL	$84.53 - $94.96 $13,017 - $14,623	-154 Reduced 0.54%	28,519 $2.46 Million
Q2 2022 Aug 30, 2022	BUY	$83.49 - $94.64 $188,353 - $213,507	2,256 Added 8.54%	28,673 $2.61 Million
Q1 2022 May 12, 2022	BUY	$73.51 - $82.4 $270,810 - $303,561	3,684 Added 16.21%	26,417 $2.17 Million
Q4 2021 Feb 16, 2022	BUY	$72.28 - $90.54 $1.64 Million - $2.06 Million	22,733 New	22,733 $1.74 Million

Others Institutions Holding MRK

# of Institutions

3,768

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $319B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raleigh Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raleigh Capital Management Inc. with notifications on news.

Account

Raleigh Capital Management Inc. Merck & Co., Inc. Transaction History